Advanced Biomed Inc. (ADVB): Valuation
TTM figures as of March 31, 2026
Advanced Biomed Inc. trades at 2.6 times trailing earnings and a -21.76% free-cash-flow yield. The Healthcare median P/E is 22.9.
Earnings yield 39.03%.
18 month-end valuation observations are on file, starting March 2025.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is ADVB cheap versus its own history?
Advanced Biomed Inc. trades at 2.6 times trailing earnings and a -21.76% free-cash-flow yield. The Healthcare median P/E is 22.9.
What is ADVB's free-cash-flow yield?
Advanced Biomed Inc. currently yields -21.76% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.